FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Kinch

Research Profile

Chemicals & Drugs

Living Beings

Phenomena

Phosphorylation

Physiology

Disorders

Anatomy

Procedures

Immunohistochemistry

Co-author Network

Publications

TOP 3
Yesim Gökmen-Polar; Rachel A Toroni; Barbara A Hocevar; Sunil Badve; Qianqian Zhao; Changyu Shen; Elizabeth M Bruckheimer; Michael S Kinch; Kathy D Miller
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
Travis K Warren; Kelly L Warfield; Jay Wells; Sven Enterlein; Mark Smith; Gordon Ruthel; Abdul S Yunus; Michael S Kinch; Michael Goldblatt; M Javad Aman; Sina Bavari
Antiviral activity of a small-molecule inhibitor of filovirus infection.
Heinz Reiske; Baoquan Sui; Huong Ung-Medoff; Robert Donahue; Wu-Bo Li; Michael Goldblatt; Limin Li; Michael S Kinch
Identification of annexin A13 as a regulator of chemotherapy resistance using random homozygous gene perturbation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Kinch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Yesim Gökmen-Polar; Rachel A Toroni; Barbara A Hocevar; Sunil Badve; Qianqian Zhao; Changyu Shen; Elizabeth M Bruckheimer; Michael S Kinch; Kathy D Miller
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
Breast cancer research and treatment 2011;127(2):375-84.
2010: Travis K Warren; Kelly L Warfield; Jay Wells; Sven Enterlein; Mark Smith; Gordon Ruthel; Abdul S Yunus; Michael S Kinch; Michael Goldblatt; M Javad Aman; Sina Bavari
Antiviral activity of a small-molecule inhibitor of filovirus infection.
Antimicrobial agents and chemotherapy 2010;54(5):2152-9.
2010: Heinz Reiske; Baoquan Sui; Huong Ung-Medoff; Robert Donahue; Wu-Bo Li; Michael Goldblatt; Limin Li; Michael S Kinch
Identification of annexin A13 as a regulator of chemotherapy resistance using random homozygous gene perturbation.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2010;32(2):61-9.
2010: Leyla Diaz; Hanwen Mao; Yu Zhou; Manu Kohli; Josephine Cassella; David Santos; Zena Fesseha; Ke Weng; Hanson Chen; Douty Bamba; James D Marks; Michael Goldblatt; Michael S Kinch
TSG101 exposure on the surface of HIV-1 infected cells: implications for monoclonal antibody therapy for HIV/AIDS.
American journal of translational research 2010;2(4):368-80.
2009: M Javad Aman; Michael S Kinch; Kelly L Warfield; Travis Warren; Abdul Yunus; Sven Enterlein; Eric Stavale; Peifang Wang; Shaojing Chang; Qingsong Tang; Kevin Porter; Michael Goldblatt; Sina Bavari
Development of a broad-spectrum antiviral with activity against Ebola virus.
Antiviral research 2009;83(3):245-51.
2009: Michael S Kinch; Manu Kohli; Michael Goldblatt; Wu-Bo Li
Function-first approaches to improve target identification in cancer.
Future oncology (London, England) 2009;5(5):617-23.
2009: Elizabeth M Bruckheimer; Christine A Fazenbaker; Sandra Gallagher; Kathy A Mulgrew; Stacy R Fuhrmann; Karen Coffman; William D Walsh; Shannon Ready; Kimberly E Cook; Melissa M Damschroder; Michael S Kinch; Peter Kiener; Rob Woods; Changshou Gao; William F Dall'Acqua; Herren Wu; Steven R Coats
Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.
Neoplasia (New York, N.Y.) 2009;11(6):509-17, 2 p following 517.
2009: Baoquan Sui; Douty Bamba; Ke Weng; Huong Ung; Shaojing Chang; Jessica Van Dyke; Michael Goldblatt; Roxanne Duan; Michael S Kinch; Wu-Bo Li
The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza.
Virology 2009;387(2):473-81.
2009: Michael S Kinch; Abdul S Yunus; Calli Lear; Hanwen Mao; Hanson Chen; Zena Fesseha; Guangxiang Luo; Eric A Nelson; Limin Li; Zhuhui Huang; Michael Murray; William Y Ellis; Lisa Hensley; Jane Christopher-Hennings; Gene Garrard Olinger; Michael Goldblatt
FGI-104: a broad-spectrum small molecule inhibitor of viral infection.
American journal of translational research 2009;1(1):87-98.
2009: Wu-Bo Li; Jie Zhu; Brit Hart; Baoquan Sui; Ke Weng; Shaojing Chang; Rebecca Geiger; Montserrat Torremorell; Alan Mileham; Christy Gladney; Martha A Mellancamp; Limin Li; Abdul Yunus; Michael Goldblatt; Michael S Kinch
Identification of PTCH1 requirement for influenza virus using random homozygous gene perturbation.
American journal of translational research 2009;1(3):259-66.
2009: Hanwen Mao; Hanson Chen; Zena Fesseha; Shaojing Chang; Huong Ung-Medoff; Jessica Van Dyke; Manu Kohli; Wu-Bo Li; Michael Goldblatt; Michael S Kinch
Identification of novel host-oriented targets for Human Immunodeficiency Virus type 1 using Random Homozygous Gene Perturbation.
Virology journal 2009;6():154.
2008: Amy Wesa; Christopher J Herrem; Maja Mandic; Jennifer L Taylor; Cecilia Vasquez; Mayumi Kawabe; Tomohide Tatsumi; Michael S Leibowitz; James H Finke; Ronald M Bukowski; Elizabeth M Bruckheimer; Michael S Kinch; Walter J Storkus
Enhancement in specific CD8+ T cell recognition of EphA2+ tumors in vitro and in vivo after treatment with ligand agonists.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(11):7721-7.
2008: Dowdy Jackson; John Gooya; Shenlan Mao; Krista L Kinneer; Linda Xu; Margarita Camara; Christine A Fazenbaker; Ryan Fleming; Sudha Swamynathan; Damon Meyer; Peter D Senter; Changshou Gao; Herren Wu; Michael S Kinch; Steven R Coats; Peter Kiener; David A Tice
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.
Cancer research 2008;68(22):9367-74.
2008: Charles N Landen; Tae-Jin Kim; Yvonne G Lin; William M Merritt; Aparna A Kamat; Liz Y Han; Whitney A Spannuth; Alpa M Nick; Nicholas B Jennnings; Michael S Kinch; David A Tice; Anil K Sood
Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.
Neoplasia (New York, N.Y.) 2008;10(11):1259-67.
2008: Chunhua Lu; Mian Shahzad; Hua Wang; Charles N Landen; Seung W Kim; Julie Allen; Alpa M Nick; Nicholas B Jennings; Michael S Kinch; Menashe Bar-Eli; Anil K Sood
EphA2 overexpression promotes ovarian cancer growth.
Cancer biology & therapy 2008;7(7):1098-103.
2007: Scott A Hammond; Ralf Lutterbuese; Shannon Roff; Petra Lutterbuese; Bernd Schlereth; Elizabeth M Bruckheimer; Michael S Kinch; Steven R Coats; Patrick A Baeuerle; Peter Kufer; Peter Kiener
Selective targeting and potent control of tumor growth using an EphA2/CD3-Bispecific single-chain antibody construct.
Cancer research 2007;67(8):3927-35.
2007: Yvonne G Lin; Liz Y Han; Aparna A Kamat; William M Merritt; Charles N Landen; Michael T Deavers; Mavis S Fletcher; Diana L Urbauer; Michael S Kinch; Anil K Sood
EphA2 overexpression is associated with angiogenesis in ovarian cancer.
Cancer 2007;109(2):332-40.
2006: Kathy A Mulgrew; Krista L Kinneer; Xiao-Tao Yao; Beth K Ward; Melissa M Damschroder; Bill Walsh; Su-Yau Mao; Changshou Gao; Peter Kiener; Steven R Coats; Michael S Kinch; David A Tice
Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin.
Molecular cancer therapeutics 2006;5(12):3122-9.
2006: Charles N Landen; Chunhua Lu; Liz Y Han; Karen Coffman; Elizabeth M Bruckheimer; Jyotsnabaran Halder; Lingegowda S Mangala; William M Merritt; Yvonne G Lin; Changshou Gao; Rosemarie Schmandt; Aparna A Kamat; Yang Li; Premal H Thaker; David M Gershenson; Nila U Parikh; Gary E Gallick; Michael S Kinch; Anil K Sood
Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Journal of the National Cancer Institute 2006;98(21):1558-70.
2006: William M Merritt; Premal H Thaker; Charles N Landen; Michael T Deavers; Mavis S Fletcher; Yvonne G Lin; Liz Y Han; Aparna A Kamat; Rosemarie Schmandt; David M Gershenson; Michael S Kinch; Anil K Sood
Analysis of EphA2 expression and mutant p53 in ovarian carcinoma.
Cancer biology & therapy 2006;5(10):1357-60.
2006: Kathryn M Zabell; Jennifer S Laurence; Michael S Kinch; Deborah W Knapp; Cynthia V Stauffacher
Expression and purification of the intact cytoplasmic domain of the human ephrin receptor A2 tyrosine kinase in Escherichia coli.
Protein expression and purification 2006;47(1):210-6.
2006: Angela R Hess; Elisabeth A Seftor; Lynn M Gruman; Michael S Kinch; Richard E B Seftor; Mary J C Hendrix
VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.
Cancer biology & therapy 2006;5(2):228-33.
2006: Shaji Abraham; Deborah W Knapp; Liang Cheng; Paul W Snyder; Suresh K Mittal; Dinesh S Bangari; Michael S Kinch; Lan Wu; Jay Dhariwal; Sulma I Mohammed
Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):353-60.
2005: Charles N Landen; Michael S Kinch; Anil K Sood
EphA2 as a target for ovarian cancer therapy.
Expert opinion on therapeutic targets 2005;9(6):1179-87.
2005: Manabu Hatano; Junichi Eguchi; Tomohide Tatsumi; Naruo Kuwashima; Jill E Dusak; Michael S Kinch; Ian F Pollack; Ronald L Hamilton; Walter J Storkus; Hideho Okada
EphA2 as a glioma-associated antigen: a novel target for glioma vaccines.
Neoplasia (New York, N.Y.) 2005;7(8):717-22.
2005: Christopher J Herrem; Tomohide Tatsumi; Kathleen S Olson; Keisuke Shirai; James H Finke; Ronald M Bukowski; Ming Zhou; Amy L Richmond; Ithaar H Derweesh; Michael S Kinch; Walter J Storkus
Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):226-31.
2004: Loren W Noblitt; Dinesh S Bangari; Shruti Shukla; Deborah W Knapp; Sulma Mohammed; Michael S Kinch; Suresh K Mittal
Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.
Cancer gene therapy 2004;11(11):757-66.
2004: Min Hu; Kelly L Carles-Kinch; Daniel P Zelinski; Michael S Kinch
EphA2 induction of fibronectin creates a permissive microenvironment for malignant cells.
Molecular cancer research : MCR 2004;2(10):533-40.
2004: Premal H Thaker; Michael Deavers; Joseph Celestino; Angela Thornton; Mavis S Fletcher; Charles N Landen; Michael S Kinch; Peter Kiener; Anil K Sood
EphA2 expression is associated with aggressive features in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5145-50.
2004: Liang Cheng; Chong-Xian Pan; Jian-Ting Zhang; Shaobo Zhang; Michael S Kinch; Lang Li; Lee Ann Baldridge; Christopher Wade; Zhiqiang Hu; Michael O Koch; Thomas M Ulbright; John N Eble
Loss of 14-3-3sigma in prostate cancer and its precursors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3064-8.
2004: Chong-Xian Pan; Michael S Kinch; Peter Kiener; Solomon Langermann; Ginette Serrero; Le Sun; Joseph Corvera; Christopher J Sweeney; Lang Li; Shaobo Zhang; Lee Ann Baldridge; Timothy D Jones; Michael O Koch; Thomas M Ulbright; John N Eble; Liang Cheng
PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1333-7.
2003: Rebecca L Pratt; Michael S Kinch
Ligand binding up-regulates EphA2 messenger RNA through the mitogen-activated protein/extracellular signal-regulated kinase pathway.
Molecular cancer research : MCR 2003;1(14):1070-6.
2003: Guangyuan Zeng; Zhiqiang Hu; Michael S Kinch; Chong-Xian Pan; David A Flockhart; Chinghai Kao; Thomas A Gardner; Shaobo Zhang; Lang Li; Lee Ann Baldridge; Michael O Koch; Thomas M Ulbright; John N Eble; Liang Cheng
High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia.
The American journal of pathology 2003;163(6):2271-6.
2003: Brenda J Irvin; Lauren D Wood; Lilin Wang; Randy Fenrick; Courtney G Sansam; Graham Packham; Michael S Kinch; Elizabeth Yang; Scott W Hiebert
TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL.
The Journal of biological chemistry 2003;278(47):46378-86.
2003: Karen Coffman; Min Hu; Kelly L Carles-Kinch; David A Tice; Nanci E Donacki; Karyn Munyon; Gizachew Kifle; Robert M Woods; Solomon Langermann; Peter Kiener; Michael S Kinch
Differential EphA2 epitope display on normal versus malignant cells.
Cancer research 2003;63(22):7907-12.
2003: Tomohide Tatsumi; Christopher J Herrem; Walter C Olson; James H Finke; Ronald M Bukowski; Michael S Kinch; Elena Ranieri; Walter J Storkus
Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma.
Cancer research 2003;63(15):4481-9.
2003: Ming Lu; Kathy D Miller; Yesim Gokmen-Polar; Meei-Huey Jeng; Michael S Kinch
EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.
Cancer research 2003;63(12):3425-9.
2003: Jennifer Walker-Daniels; Angela R Hess; Mary J C Hendrix; Michael S Kinch
Differential regulation of EphA2 in normal and malignant cells.
The American journal of pathology 2003;162(4):1037-42.
2003: Mary Fedor-Chaiken; Patrick W Hein; Jane C Stewart; Robert Brackenbury; Michael S Kinch
E-cadherin binding modulates EGF receptor activation.
Cell communication & adhesion 2003;10(2):105-18.
2003: Michael S Kinch; Mary-Beth H Moore; David H Harpole
Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):613-8.
2003: Michael S Kinch; Kelly L Carles-Kinch
Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer.
Clinical & experimental metastasis 2003;20(1):59-68.
2002: Jennifer Walker-Daniels; David J Riese; Michael S Kinch
c-Cbl-dependent EphA2 protein degradation is induced by ligand binding.
Molecular cancer research : MCR 2002;1(1):79-87.
2002: Rebecca L Pratt; Michael S Kinch
Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade.
Oncogene 2002;21(50):7690-9.
2002: Keith D Kikawa; Derika R Vidale; Robert L Van Etten; Michael S Kinch
Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation.
The Journal of biological chemistry 2002;277(42):39274-9.
2002: Kelly L Carles-Kinch; Katherine E Kilpatrick; Jane C Stewart; Michael S Kinch
Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior.
Cancer research 2002;62(10):2840-7.
2002: Daniel P Zelinski; Nicole Dodge Zantek; Jennifer Walker-Daniels; Mette A Peters; Elizabeth J Taparowsky; Michael S Kinch
Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase.
Journal of cellular biochemistry 2002;85(4):714-20.
2001: Nicole Dodge Zantek; Jennifer Walker-Daniels; J Stewart; R K Hansen; D Robinson; H Miao; B Wang; Hsing-Jien Kung; M J Bissell; Michael S Kinch
MCF-10A-NeoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(11):3640-8.
2001: Thomas A D'Amico; Thomas A Aloia; Mary-Beth H Moore; Debbi H Conlon; James E Herndon; Michael S Kinch; David H Harpole
Predicting the sites of metastases from lung cancer using molecular biologic markers.
The Annals of thoracic surgery 2001;72(4):1144-8.
2001: Angela R Hess; Elisabeth A Seftor; L M G Gardner; Kelly L Carles-Kinch; Galen B Schneider; Richard E B Seftor; Michael S Kinch; Mary J C Hendrix
Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
Cancer research 2001;61(8):3250-5.
2001: Daniel P Zelinski; Nicole Dodge Zantek; Jane C Stewart; A R Irizarry; Michael S Kinch
EphA2 overexpression causes tumorigenesis of mammary epithelial cells.
Cancer research 2001;61(5):2301-6.
2001: Michael S Kinch
Cytometric analysis of cell contact and adhesion.
Methods in cell biology 2001;63():599-612.
2001: Nicole Dodge Zantek; Michael S Kinch
Analysis of cell migration.
Methods in cell biology 2001;63():549-59.
2000: Randy Fenrick; Lilin Wang; John Nip; Joseph M Amann; Robert J. Rooney; Jennifer Walker-Daniels; Howard C Crawford; Diana L Hulboy; Michael S Kinch; Lynn M Matrisian; Scott W Hiebert
TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1.
Molecular and cellular biology 2000;20(16):5828-39.
2000: Hui Miao; E Burnett; Michael S Kinch; E Simon; Bingcheng Wang
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation.
Nature cell biology 2000;2(2):62-9.
1999: Jennifer Walker-Daniels; Karen Coffman; M Azimi; J S Rhim; D G Bostwick; P Snyder; B J Kerns; David J Waters; Michael S Kinch
Overexpression of the EphA2 tyrosine kinase in prostate cancer.
The Prostate 1999;41(4):275-80.
1999: Nicole Dodge Zantek; M Azimi; Mary Fedor-Chaiken; B Wang; Robert Brackenbury; Michael S Kinch
E-cadherin regulates the function of the EphA2 receptor tyrosine kinase.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1999;10(9):629-38.
1999: L A Miller; J J Hong; Michael S Kinch; Marietta L Harrison; Robert L Geahlen
The engagement of beta1 integrins on promonocytic cells promotes phosphorylation of Syk and formation of a protein complex containing Lyn and beta1 integrin.
European journal of immunology 1999;29(5):1426-34.
1998: Mark E Stearns; J L Ware; D B Agus; C J Chang; I J Fidler; R S Fife; R Goode; E Holmes; Michael S Kinch; D M Peehl; T G Pretlow; G N Thalmann
Workgroup 2: human xenograft models of prostate cancer.
The Prostate 1998;36(1):56-8.
1998: Michael S Kinch; K E Kilpatrick; C Zhong
Identification of tyrosine phosphorylated adhesion proteins in human cancer cells.
Hybridoma 1998;17(3):227-35.
1998: Susann M Brady-Kalnay; Tracy L Mourton; J P Nixon; G E Pietz; Michael S Kinch; H Chen; R Brackenbury; D L Rimm; Robert L Del Vecchio; N K Tonks
Dynamic interaction of PTPmu with multiple cadherins in vivo.
The Journal of cell biology 1998;141(1):287-96.
1997: C Zhong; Michael S Kinch; Keith Burridge
Rho-stimulated contractility contributes to the fibroblastic phenotype of Ras-transformed epithelial cells.
Molecular biology of the cell 1997;8(11):2329-44.
1997: Edward T O'Brien; Michael S Kinch; T W Harding; David L Epstein
A mechanism for trabecular meshwork cell retraction: ethacrynic acid initiates the dephosphorylation of focal adhesion proteins.
Experimental eye research 1997;65(4):471-83.
1997: Geoffrey J Clark; Michael S Kinch; Kelley Rogers-Graham; S M Sebti; A D Hamilton; Channing J Der
The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation.
The Journal of biological chemistry 1997;272(16):10608-15.
1997: Michael S Kinch; Leslie Petch; C Zhong; Keith Burridge
E-cadherin engagement stimulates tyrosine phosphorylation.
Cell adhesion and communication 1997;4(6):425-37.
1996: Geoffrey J Clark; Michael S Kinch; T M Gilmer; Keith Burridge; Channing J Der
Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers.
Oncogene 1996;12(1):169-76.
1995: Roya Khosravi-Far; P A Solski; Geoffrey J Clark; Michael S Kinch; Channing J Der
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation.
Molecular and cellular biology 1995;15(11):6443-53.
1995: Michael S Kinch; Keith Burridge
Altered adhesions in ras-transformed breast epithelial cells.
Biochemical Society transactions 1995;23(3):446-50.
1995: Michael S Kinch; Geoffrey J Clark; Channing J Der; Keith Burridge
Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia.
The Journal of cell biology 1995;130(2):461-71.
1994: Michael S Kinch; A Sanfridson; Carolyn Doyle
The protein tyrosine kinase p56lck regulates cell adhesion mediated by CD4 and major histocompatibility complex class II proteins.
The Journal of experimental medicine 1994;180(5):1729-39.
1994: Q Chen; Michael S Kinch; T H Lin; Keith Burridge; Rudy L Juliano
Integrin-mediated cell adhesion activates mitogen-activated protein kinases.
The Journal of biological chemistry 1994;269(43):26602-5.
1993: Michael S Kinch; Jack L Strominger; Carolyn Doyle
Cell adhesion mediated by CD4 and MHC class II proteins requires active cellular processes.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(9):4552-61.
1993: D A Vignali; Carolyn Doyle; Michael S Kinch; J Shin; Jack L Strominger
Interactions of CD4 with MHC class II molecules, T cell receptors and p56lck.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1993;342(1299):13-24.
1993: Allan D Kirk; R A Li; Michael S Kinch; K A Abernethy; Carolyn Doyle; R Randal Bollinger
The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness.
Transplantation 1993;55(4):924-31.